Skip to main content
NIH
Closed

PAR-24-113

International Research Scientist Development Award (IRSDA) (K01) Independent Clinical Trial Not Allowed

Summary

AI-generated

International Research Scientist Development Award (IRSDA) (K01)

STATUS: EXPIRED (March 10, 2026). Limited case-by-case acceptance may apply; contact eRA Service Desk.

Research Focus

The IRSDA supports advanced postdoctoral researchers and junior faculty (≥2 years post-doctorate) conducting mentored global health research in low- and middle-income countries (LMICs, as defined by World Bank classification). The program targets health-related disciplines addressing LMIC health priorities through intensive, collaborative research that does not involve leading an independent clinical trial. Awardees develop expertise in research methodology, data management, grant writing, and collaborative research in low-resource settings while establishing sustained international partnerships. The goal is to prepare researchers for independent global health research careers competitive for R01 funding.

Participating NIH components emphasize diverse research areas: FIC supports any therapeutic or scientific health priority; NCI prioritizes cancer biology, epidemiology, prevention, clinical/translational research, implementation science, health systems research, and cancer informatics; NIDCD focuses on hearing loss, otitis media, early hearing detection and intervention, chemosensory loss, and dissemination/implementation research for communication disorders.

At a Glance

  • Who can apply: U.S. postdoctoral research scientists and recently-appointed junior faculty (any health-related discipline) from U.S. institutions; must be ≥2 years beyond doctoral degree conferral.
  • Funding & project length: 3–5 years of protected time; specific award amount not stated.
  • Award mechanism: K01 Research Scientist Development Award (mentored career development).
  • Key dates: Application due dates on March 10, 2025 and March 9, 2026 (rolling cycles); earliest start July 2024 onward.
  • Best fit for: Global health researchers in any discipline (oncology, otolaryngology, infectious disease, etc.) planning ≥50% cumulative effort and ≥3 months/year in-country research in LMICs under dual U.S.–LMIC mentorship.

Key Facts

Deadline

Mon, March 9, 2026

Posted

Mon, January 22, 2024

93.398
93.173
93.989
Grants.gov
Agency

Research Areas

NIH Institute
National Cancer InstituteNCI

AI-generated content — verify with the issuing agency’s official FOA/NOFO. Not endorsed by HHS.

© 2026 Biostochastics, Seattle WA · Contact · Terms · About